Bilix

Yongin, South Korea · Founded 2018 · Privately Held (backing)

Developer of PEGylated bilirubin nanoparticles designed to treat ischemia-reperfusion injury by reducing inflammation and oxidative stress. Bilix is based in Yongin, South Korea and was founded in 2018. Its last reported valuation was $28.1 million in Dec 2025. It has raised $10 million.

Last reported valuation

$28.1M

Oct 2026

Priced at

—

Total raised

$10.0M

Last round

—

How much has Bilix raised?

$10.0Macross 0 recorded rounds

Free account

More of Bilix with a free account

·The complete investor list: 15 names
·Watch Bilix: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Bilix investors

15 investors are on record for Bilix, including iM Investment Partners, BiiG WAVE, Magna Investment (Seoul) and Alpen Route Asset Management.

For fundraisers

Raising for a company like Bilix?

15 investors have backed Bilix.

See all 15 investors →

Frequently asked about Bilix

How much has Bilix raised?: Bilix has raised $10.0M in total across 0 recorded funding rounds.